3D printing is one of the revolutionary technologies that has taken over the world in the 21st century, and it has expanded its wings to encompass different industries and end-users. The healthcare sector is witnessing significant traction in the use of 3D printing for healthcare. The active support from the governments and the industry players in increasing the awareness regarding the benefits of using 3D printing over conventional methods of manufacturing serves as a substantial factor attributed to the growth of the global 3D printing market. The ongoing technological advancements such as incorporation of new materials and surface enhancement of the final model, ease in the development of customized products, reduction in manufacturing cost, and government investments in 3D printing projects are some of the other favorable factors for the growth of the 3D printing market.

According to the report titled ‘Global Bioprinting Market– Analysis and Forecast (2018-2025)’, the global bioprinting market is expected to reach a value of $4.70 billion by 2025. Bioprinting which is a subset of 3D printing works on the same principle as of 3D printing except the procedure is performed using living cells, tissues, and organs, where the complexities of tissues and cells such as cell types, functionalities, growth, and differentiation patterns are addressed. It is the artificial construction of living tissues by putting layer upon layer of living cells.

The advent of 3D bioprinting technologies has led to significant progress in the manufacturing of large bioartificial organs, such as bones, livers, hearts, cartilages, and skins. It can produce living tissues, blood vessels, and potentially whole organs for its usage in medical procedures, drug discovery & testing, tissue engineering research & study, and others. The advantages of 3D bioprinting over other fabrication techniques are: it enables fabrication of anatomically correct shapes, allows fabrication of porous structures, can co-culture multiple cell types locally, and control the delivery of growth factors and genes, as well as can generate tissue models in a high-throughput manner and integrate vascularization.

Growing demand for organ transplantation, rise in public & private funding to support 3D bioprinting research activities, increasing usage of 3D bioprinting in drug discovery process, increasing geriatric population, and active participation of the government and the industry players in the technological advancement in the field of 3D bioprinting are the factors that have boosted the overall growth of this market.

The widening gap between the demand and the supply of organ transplants represent a vast unmet need amongst the patients and doctors. The emerging bioprinting technologies have a strong potential in filling this gap in the future. The eventual goal of researchers is to be able to produce printed organs for organ implants. The market is expected to progress gradually over the coming years with the focus of shifting from research to commercialization. The early success of the bio printed organ transplants is likely to provide an additional boost in subsequent years.

BIS Research has conducted extensive research on the global bioprinting market and compiled the observation and insight in this report. The market intelligence report aims at providing an in-depth analysis of the key development strategies, marketing strategies and market trend dynamics which include drivers, restraints, and opportunities prevailing in the industry.

For further queries, please write to us at sales@bisresearch.com or call us at: +1 650 228 0182.